Our April 2018 newsletter is online. Find it here.

In this newsletter we highlight:

  • Updates on our endeavors in impact investing in life sciences
  • Start of a collaboration with Malta to redesign market access evaluations
  • Enrollment in our epilepsy seizure dog trial
  • Closing of the prostate cancer registry